{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:33:35Z","timestamp":1759991615767,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Ministry of Health, Labour and Welfare of Japan."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12865-017-0191-2","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T08:52:20Z","timestamp":1486111940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5487-4692","authenticated-orcid":false,"given":"Shoichi","family":"Fukui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsufumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"issue":"5","key":"191_CR1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/aid.1993.9.381","volume":"9","author":"G de The","year":"1993","unstructured":"de The G, Bomford R. An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retrovir. 1993;9(5):381\u20136. published Online First: 1993\/05\/01.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"4","key":"191_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/s1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck K, Gonzalez E, Van Dooren S, et al. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7(4):266\u201381. doi: 10.1016\/s1473-3099(07)70081-6 . published Online First: 2007\/03\/23.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"191_CR3","first-page":"1096","volume":"3","author":"JE Kaplan","year":"1990","unstructured":"Kaplan JE, Osame M, Kubota H, et al. The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr. 1990;3(11):1096\u2013101 [published Online First: 1990\/01\/01].","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"22","key":"191_CR4","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1056\/nejm200011303432201","volume":"343","author":"JM Bathon","year":"2000","unstructured":"Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000;343(22):1586\u201393. doi: 10.1056\/nejm200011303432201 . published Online First: 2000\/11\/30.","journal-title":"N Engl J Med"},{"issue":"18","key":"191_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa012664","volume":"346","author":"JD Gorman","year":"2002","unstructured":"Gorman JD, Sack KE, Davis Jr JC. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med. 2002;346(18):1349\u201356. doi: 10.1056\/NEJMoa012664 . published Online First: 2002\/05\/03.","journal-title":"N Engl J Med"},{"issue":"23","key":"191_CR6","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353(23):2462\u201376. doi: 10.1056\/NEJMoa050516 . published Online First: 2005\/12\/13.","journal-title":"N Engl J Med"},{"issue":"5","key":"191_CR7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00004836-199010000-00015","volume":"12","author":"S Gupta","year":"1990","unstructured":"Gupta S, Govindarajan S, Fong TL, et al. Spontaneous reactivation in chronic hepatitis B: patterns and natural history. J Clin Gastroenterol. 1990;12(5):562\u20138. published Online First: 1990\/10\/01.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"191_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jmv.23181","volume":"84","author":"M Satake","year":"2012","unstructured":"Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84(2):327\u201335. doi: 10.1002\/jmv.23181 . published Online First: 2011\/12\/16.","journal-title":"J Med Virol"},{"key":"191_CR9","doi-asserted-by":"publisher","first-page":"i262","DOI":"10.1136\/bmj.i262","volume":"352","author":"P Raaschou","year":"2016","unstructured":"Raaschou P, Simard JF, Asker Hagelberg C, et al. Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden. BMJ (Clinical research ed). 2016;352:i262. doi: 10.1136\/bmj.i262 . published Online First: 2016\/01\/30.","journal-title":"BMJ (Clinical research ed)"},{"issue":"5","key":"191_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3109\/14397595.2016.1141740","volume":"26","author":"M Harigai","year":"2016","unstructured":"Harigai M, Nanki T, Koike R, et al. Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan. Modern Rheumatol Japan Rheum Assoc. 2016;26(5):642\u201350. doi: 10.3109\/14397595.2016.1141740 . published Online First: 2016\/02\/14.","journal-title":"Modern Rheumatol Japan Rheum Assoc"},{"issue":"4","key":"191_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jbspin.2013.10.006","volume":"81","author":"L Frenzel","year":"2014","unstructured":"Frenzel L, Moura B, Marcais A, et al. HTLV-1-associated arthropathy treated with anti-TNF-alpha agent. Joint Bone Spine. 2014;81(4):360\u20131. doi: 10.1016\/j.jbspin.2013.10.006 . published Online First: 2013\/12\/03.","journal-title":"Joint Bone Spine"},{"issue":"8","key":"191_CR12","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M, Watanabe T, Utsunomiya A, et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;116(8):1211\u20139. doi: 10.1182\/blood-2009-12-257410 . published Online First: 2010\/05\/08.","journal-title":"Blood"},{"issue":"11","key":"191_CR13","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/j.1349-7006.2010.01720.x","volume":"101","author":"S Kamihira","year":"2010","unstructured":"Kamihira S, Yamano Y, Iwanaga M, et al. Intra- and inter-laboratory variability in human T-cell leukemia virus type-1 proviral load quantification using real-time polymerase chain reaction assays: a multi-center study. Cancer Sci. 2010;101(11):2361\u20137. doi: 10.1111\/j.1349-7006.2010.01720.x . published Online First: 2010\/09\/30.","journal-title":"Cancer Sci"},{"issue":"5887","key":"191_CR14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/300063a0","volume":"300","author":"M Popovic","year":"1982","unstructured":"Popovic M, Reitz Jr MS, Sarngadharan MG, et al. The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature. 1982;300(5887):63\u20136. published Online First: 1982\/11\/04.","journal-title":"Nature"},{"issue":"12","key":"191_CR15","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1073\/pnas.80.12.3618","volume":"80","author":"M Seiki","year":"1983","unstructured":"Seiki M, Hattori S, Hirayama Y, et al. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A. 1983;80(12):3618\u201322. published Online First: 1983\/06\/01.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"191_CR16","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1128\/JVI.77.17.9716-9722.2003","volume":"77","author":"PK Goon","year":"2003","unstructured":"Goon PK, Igakura T, Hanon E, et al. High circulating frequencies of tumor necrosis factor alpha-and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease. J Virol. 2003;77(17):9716\u201322.","journal-title":"J Virol"},{"issue":"4","key":"191_CR17","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/art.39009","volume":"67","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Takahashi Y, Yamamoto-Fukuda T, et al. Direct infection of primary salivary gland epithelial cells by human T lymphotropic virus type I in patients with Sjogren\u2019s syndrome. Arthritis Rheumatol (Hoboken, NJ). 2015;67(4):1096\u2013106. doi: 10.1002\/art.39009 . published Online First: 2014\/12\/30.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"2","key":"191_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/15216540500078715","volume":"57","author":"EW Harhaj","year":"2005","unstructured":"Harhaj EW, Harhaj NS. Mechanisms of persistent NF-kappaB activation by HTLV-I tax. IUBMB Life. 2005;57(2):83\u201391. doi: 10.1080\/15216540500078715 . published Online First: 2005\/07\/23.","journal-title":"IUBMB Life"},{"issue":"12","key":"191_CR19","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/onc.2010.537","volume":"30","author":"M Matsuoka","year":"2011","unstructured":"Matsuoka M, Jeang KT. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene. 2011;30(12):1379\u201389. doi: 10.1038\/onc.2010.537 . published Online First: 2010\/12\/02.","journal-title":"Oncogene"},{"issue":"3","key":"191_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/13550280152403272","volume":"7","author":"T Matsuzaki","year":"2001","unstructured":"Matsuzaki T, Nakagawa M, Nagai M, et al. HTLV-I proviral load correlates with progression of motor disability in HAM\/TSP: analysis of 239 HAM\/TSP patients including 64 patients followed up for 10 years. J Neurovirol. 2001;7(3):228\u201334. doi: 10.1080\/13550280152403272 . published Online First: 2001\/08\/23.","journal-title":"J Neurovirol"},{"issue":"5","key":"191_CR21","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3109\/14397595.2013.844389","volume":"25","author":"K Umekita","year":"2015","unstructured":"Umekita K, Umeki K, Miyauchi S, et al. Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series. Modern Rheumatol Japan Rheum Assoc. 2015;25(5):794\u20137. doi: 10.3109\/14397595.2013.844389 . published Online First: 2013\/11\/21.","journal-title":"Modern Rheumatol Japan Rheum Assoc"},{"issue":"9","key":"191_CR22","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","volume":"72","author":"EA Carswell","year":"1975","unstructured":"Carswell EA, Old LJ, Kassel RL, et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975;72(9):3666\u201370. published Online First: 1975\/09\/01.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"191_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9(5):361\u201371. doi: 10.1038\/nrc2628 . published Online First: 2009\/04\/04.","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"191_CR24","doi-asserted-by":"publisher","first-page":"10638","DOI":"10.1158\/0008-5472.can-07-2587","volume":"67","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Watanabe T, Kannagi M, et al. Meeting report on the 13th International Conference on Human Retrovirology: human T-cell leukemia virus research 30 years after adult T-cell leukemia. Cancer Res. 2007;67(22):10638\u201341. doi: 10.1158\/0008-5472.can-07-2587 . published Online First: 2007\/11\/13.","journal-title":"Cancer Res"},{"issue":"4660","key":"191_CR25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.6330891","volume":"225","author":"JG Sodroski","year":"1984","unstructured":"Sodroski JG, Rosen CA, Haseltine WA. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science (New York, NY). 1984;225(4660):381\u20135. published Online First: 1984\/07\/27.","journal-title":"Science (New York, NY)"},{"issue":"9","key":"191_CR26","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","volume":"112","author":"J Arnold","year":"2008","unstructured":"Arnold J, Zimmerman B, Li M, et al. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood. 2008;112(9):3788\u201397. doi: 10.1182\/blood-2008-04-154286 . published Online First: 2008\/08\/12.","journal-title":"Blood"},{"issue":"4","key":"191_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/carcin\/bgi274","volume":"27","author":"Y Tabakin-Fix","year":"2006","unstructured":"Tabakin-Fix Y, Azran I, Schavinky-Khrapunsky Y, et al. Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications. Carcinogenesis. 2006;27(4):673\u201381. doi: 10.1093\/carcin\/bgi274 . published Online First: 2005\/11\/26.","journal-title":"Carcinogenesis"},{"issue":"3","key":"191_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.clim.2005.01.007","volume":"115","author":"C Shen","year":"2005","unstructured":"Shen C, Maerten P, Geboes K, et al. Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model. Clin Immunol (Orlando, Fla). 2005;115(3):250\u20139. doi: 10.1016\/j.clim.2005.01.007 . published Online First: 2005\/05\/17.","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"1","key":"191_CR29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.MIB.0000194185.69800.07","volume":"12","author":"C Shen","year":"2006","unstructured":"Shen C, Van Assche G, Rutgeerts P, et al. Caspase activation and apoptosis induction by adalimumab: demonstration in vitro and in vivo in a chimeric mouse model. Inflamm Bowel Dis. 2006;12(1):22\u20138. published Online First: 2005\/12\/24.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"191_CR30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2004.11.060","volume":"128","author":"H Mitoma","year":"2005","unstructured":"Mitoma H, Horiuchi T, Hatta N, et al. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology. 2005;128(2):376\u201392. published Online First: 2005\/02\/03.","journal-title":"Gastroenterology"},{"issue":"8","key":"191_CR31","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1172\/jci75250","volume":"124","author":"N Araya","year":"2014","unstructured":"Araya N, Sato T, Ando H, et al. HTLV-1 induces a Th1-like state in CD4\u2009+\u2009CCR4+ T cells. J Clin Invest. 2014;124(8):3431\u201342. doi: 10.1172\/jci75250 . published Online First: 2014\/06\/25.","journal-title":"J Clin Invest"},{"issue":"2","key":"191_CR32","doi-asserted-by":"publisher","first-page":"e1001274","DOI":"10.1371\/journal.ppat.1001274","volume":"7","author":"Y Satou","year":"2011","unstructured":"Satou Y, Yasunaga J, Zhao T, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011;7(2):e1001274. doi: 10.1371\/journal.ppat.1001274 . published Online First: 2011\/02\/25.","journal-title":"PLoS Pathog"},{"issue":"5","key":"191_CR33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/13550289609146899","volume":"2","author":"M Nakagawa","year":"1996","unstructured":"Nakagawa M, Nakahara K, Maruyama Y, et al. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/ tropical spastic paraparesis. J Neurovirol. 1996;2(5):345\u201355. published Online First: 1996\/10\/01.","journal-title":"J Neurovirol"},{"issue":"6","key":"191_CR34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00917473","volume":"10","author":"SK Dower","year":"1990","unstructured":"Dower SK, Smith CA, Park LS. Human cytokine receptors. J Clin Immunol. 1990;10(6):289\u201399. published Online First: 1990\/11\/01.","journal-title":"J Clin Immunol"},{"issue":"2","key":"191_CR35","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cyto.2015.08.260","volume":"76","author":"E Brzustewicz","year":"2015","unstructured":"Brzustewicz E, Bryl E. The role of cytokines in the pathogenesis of rheumatoid arthritis--Practical and potential application of cytokines as biomarkers and targets of personalized therapy. Cytokine. 2015;76(2):527\u201336. doi: 10.1016\/j.cyto.2015.08.260 . published Online First: 2015\/09\/01.","journal-title":"Cytokine"},{"issue":"12","key":"191_CR36","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.leukres.2005.05.006","volume":"29","author":"RE Kast","year":"2005","unstructured":"Kast RE. Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities--the role of bupropion. Leuk Res. 2005;29(12):1459\u201363. doi: 10.1016\/j.leukres.2005.05.006 . published Online First: 2005\/06\/21.","journal-title":"Leuk Res"},{"issue":"4","key":"191_CR37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7(4):270\u201380. doi: 10.1038\/nrc2111 . published Online First: 2007\/03\/27.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"191_CR38","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1073\/pnas.0507631103","volume":"103","author":"Y Satou","year":"2006","unstructured":"Satou Y, Yasunaga J, Yoshida M, et al. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A. 2006;103(3):720\u20135. doi: 10.1073\/pnas.0507631103 . published Online First: 2006\/01\/13.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"191_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12185-011-0937-1","volume":"94","author":"J Yasunaga","year":"2011","unstructured":"Yasunaga J, Matsuoka M. Molecular mechanisms of HTLV-1 infection and pathogenesis. Int J Hematol. 2011;94(5):435\u201342. doi: 10.1007\/s12185-011-0937-1 . published Online First: 2011\/09\/29.","journal-title":"Int J Hematol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-017-0191-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:42:05Z","timestamp":1498369325000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-017-0191-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["191"],"URL":"https:\/\/doi.org\/10.1186\/s12865-017-0191-2","relation":{},"ISSN":["1471-2172"],"issn-type":[{"type":"electronic","value":"1471-2172"}],"subject":[],"published":{"date-parts":[[2017,2,3]]},"article-number":"7"}}